SCYNEXIS share price logo

SCYNEXIS

NASDAQ: SCYX

$5.23

+0.06

(+1.16%)

as on

SCYNEXIS Stock Performance

as on September 3, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.13
    $5.30
    downward going graph

    1.91%

    Downside

    1.34%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.53
    $10.48
    downward going graph

    32.50%

    Downside

    100.38%

    Upside

    downward going graph

SCYNEXIS share price movements today

Previous Close
$5.17
Open
$5.15
Volume
193.7K
Market Cap
$52.0M
Day's Low - High
$5.13 - $5.30
52 Week Low - High
$3.53 - $10.48

SCYNEXIS Historical Returns

1 Month Return
+ 6.82 %
3 Month Return
+ 1.37 %
1 Year Return
-22.65 %
3 Year Return
-82.27 %
5 Year Return
-90.31 %

SCYNEXIS Stock Fundamentals & Key Indicators

Check SCYNEXIS market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$52.0M

EPS (TTM)

-1.84

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.82

Industry PE ratio

-7.783461538461538

PEG Ratio

0.008534868469569527

EBITDA

-10.2M

Revenue (TTM)

19.2M

Profit Margin

100.00%

Return On Equity TTM

-21.10%

SCYNEXIS Stock Valuation

Track how SCYNEXIS P/E has moved over time to understand its valuation trends.

SCYNEXIS in the last 5 years

  • Overview

  • Trends

Lowest (-4.90x)

December 31, 2021

Industry (-7.78x)

December 31, 2025

Today (-3.67x)

December 31, 2025

Highest (1.59x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -3.67x

SCYNEXIS vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of SCYNEXIS with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SCYNEXIS image
SCYNEXIS
BUY$52.0M-90.31%-2.82100.00%NA
United Therapeutics image
United Therapeutics
BUY$22.0B141.49%16.5886.14%NA
Viatris image
Viatris
HOLD$19.0B9.91%-46.4434.83%2.87%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
BUY$44.4BNA20.4714.55%121.78%
Zoetis image
Zoetis
BUY$31.9B-63.08%12.4770.87%2.76%
See all

Stock Returns calculator for SCYNEXIS Stock including INR - Dollar returns

The SCYNEXIS stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

SCYNEXIS investment value today

Current value as on today

₹84,437

Returns

-₹15,563

(-15.56%)

Returns from SCYNEXIS Stock

-₹21,753 (-21.75%)

Dollar Impact

₹6,191 (+6.19%)

Analyst Recommendation on SCYNEXIS Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for SCYNEXIS. Average target price of $36.55

SCYNEXIS Share Price Target

Get share price movements and forecasts by analysts on SCYNEXIS.

What analysts predicted

85.69%UPSIDE

Target Price

$36.55

Current Price

$5.23

Analyzed by

2 Analysts

Target

$36.55

SCYNEXIS target price $36.55, a slight upside of 85.69% compared to current price of $5.23. According to 2 analysts rating.

Indian Investors' Interest in SCYNEXIS Stock

Search interest for SCYNEXIS Stock has increased by 273% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:273% versus previous 30 day period

SCYNEXIS Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
0
0
0
0
1
0
18
-
0
Gross Profit
1
0
0
0
0
1
0
18
-
0
Operating Income
-9
-9
-10
-8
-8
-9
-8
10
-16
-7
EBITDA
1
-13
-2
-3
-4
-6
-8
12
-21
7
Interest Expense
0
0
0
0
0
-
-
-
-
-
Depreciation
-
0
0
0
0
-
-
-
-
-
Income Before Tax
0
-14
-3
-4
-5
-6
-8
12
-21
7
Income Tax Expense
0
-
0
0
-
-
-
-
-
-
Net Income
0
-14
-2
-4
-5
-6
-8
12
-21
7
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
0.00%
100.00%

SCYNEXIS Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
-
13
5
140
3
20
Gross Profit
0
0
0
0
12
4
124
3
20
Operating Income
-26
-29
-48
-51
-60
-85
72
-37
-16
EBITDA
-23
-17
-51
-55
-32
-59
70
-18
-8
Interest Expense
1
2
2
1
3
6
6
2
0
Depreciation
0
0
0
0
0
0
0
1
0
Income Before Tax
-25
-19
-53
-58
-35
-67
67
-21
-8
Income Tax Expense
-
-6
-
-3
-3
-4
0
0
-
Net Income
-25
-12
-53
-55
-32
-62
67
-21
-8
Net Profit Margin
100.00%
100.00%
100.00%
0.00%
97.63%
87.66%
88.85%
100.00%
100.00%

SCYNEXIS Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
-14
-2
-4
-5
-6
-8
12
-21
7
Operating Cash Flow
-4
-10
0
-9
-7
-7
-8
18
-8
-14
Investing Cash Flow
5
1
1
-2
12
11
12
-11
0
-24
Financing Cash Flow
0
-
0
0
-14
-
0
0
24
13
Change in Cash
1
-9
2
-12
-9
3
3
6
15
-26

SCYNEXIS Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-25
-12
-53
-55
-32
-62
67
-21
-8
Operating Cash Flow
-24
-28
-38
-49
-54
-79
60
-24
-5
Investing Cash Flow
-9
0
26
6
-1
-27
-34
6
24
Financing Cash Flow
9
29
42
94
67
48
-36
0
-14
Change in Cash
-24
0
30
51
11
-58
-11
-17
4

Mutual Funds that own SCYNEXIS Stock

Check out the Mutual Funds with significant holdings in SCYNEXIS.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
15.72321%
1564398
Fidelity Concord Street Trust
3.682596%
366404
Victory Portfolios III
0.035297%
3512

Global Institutional Holdings in SCYNEXIS

Funds
Holdings
Vanguard
4.22%
Michael Rockefeller
3.89%
Bridgeway
0.16%
Dimensional
0.05%

Insights on SCYNEXIS

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -21.29M → 7.39M (in $), with an average increase of 387.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 57.6% return, outperforming this stock by 80.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 54.1% return, outperforming this stock by 136.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 18.64M → 235.0K (in $), with an average decrease of 98.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SCYX stock has moved down by -6.3%

About SCYNEXIS

SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
OrganisationSCYNEXIS
Headquarters1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548
IndustryDrug Manufacturers - Specialty & Generic
CEODr. David Gonzalez Angulo M.D.
E-voting on sharesClick here to vote

Key Management of SCYNEXIS

Name

Title

Dr. David Gonzalez Angulo M.D.

CEO, President & Director

Mr. Ivor Macleod CPA, M.B.A.

Chief Financial Officer

Mr. Scott Sukenick J.D.

Chief Legal Officer & Corporate Secretary

Ms. Daniella Gigante

Vice President of Human Resources & Information Technology

FAQs

What is SCYNEXIS share price today?

SCYNEXIS share price today is $5.23 as on at the close of the market. SCYNEXIS share today touched a day high of $5.30 and a low of $5.13.

What is the 52 week high and 52 week low for SCYNEXIS share?

SCYNEXIS share touched a 52 week high of $10.48 on and a 52 week low of $3.53 on . SCYNEXIS stock price today i.e. is closed at $5.23,which is 50.10% down from its 52 week high and 48.16% up from its 52 week low.

What is SCYNEXIS's market capitalisation today?

SCYNEXIS market capitalisation is $0.00T as on .

How to invest in SCYNEXIS Stock (SCYX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for SCYNEXIS on INDmoney app. Click on Buy button. You can invest as low as $1.5 in SCYNEXIS Shares that will get you 0.2868 shares as per SCYNEXIS share price of $5.23 per share as on September 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy SCYNEXIS Stock (SCYX) from India?

Indian investors can start investing in SCYNEXIS (SCYX) shares with as little as ₹94.96 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in SCYNEXIS stock (as per the Rupee-Dollar exchange rate as on ). Based on SCYNEXIS share’s latest price of $5.23 as on September 3, 2026 at 1:29 am IST, you will get 1.9120 shares of SCYNEXIS. Learn more about fractional shares .

What are the returns that SCYNEXIS has given to Indian investors in the last 5 years?

SCYNEXIS stock has given -90.31% share price returns and 30.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?